Home Medicine Relationship between HOMA-IR and serum vitamin D in Chinese children and adolescents
Article
Licensed
Unlicensed Requires Authentication

Relationship between HOMA-IR and serum vitamin D in Chinese children and adolescents

  • Lingli Wang , Huiyan Wang , Huaikai Wen , Hongqun Tao and Xiaowei Zhao EMAIL logo
Published/Copyright: April 18, 2016

Abstract

Background: The objective of this study was to examine the cross-sectional relationship between homeostasis model assessment for insulin resistance (HOMA-IR) and serum 25-hydroxyvitamin D (25-OHD) level in Chinese children and adolescents.

Methods: Anthropometric indices, lipid metabolic profile, and serum levels of glucose, insulin and 25-OHD were determined among 278 healthy prepubertal and pubertal, normal and overweight/obese children and adolescents aged 8–18 years between March 2014 and February 2015.

Results: HOMA-IR was significantly different across vitamin D statuses (p<0.001), even after adjusting for body mass index (BMI) (p=0.035) and waist-to-height ratio (p=0.044); the difference was not significant between the vitamin D deficient and insufficient groups (p=0.120). HOMA-IR negatively correlated with serum 25-OHD level for all subjects (R2=0.148, p<0.001). Furthermore, they negatively correlated in the normal (R2=0.160, p<0.001) and overweight/obese (R2=0.086, p<0.001) groups, respectively. The regression lines of the two groups were parallel (p=0.669) but had a significantly different intercept (p<0.001). An association between HOMA-IR and BMI and serum 25-OHD level (R2=0.654, p<0.001) was demonstrated based on the stepwise multiple linear regression analysis of age, sex, pubertal maturation, BMI, waist-to-height ratio, triglyceride, cholesterol, high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), 25-OHD and HOMA-IR.

Conclusions: Our findings supported that lower vitamin D status is strongly associated with worse HOMA-IR.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 2012;33:456–92.10.1210/er.2012-1000Search in Google Scholar PubMed PubMed Central

2. Pilz S, Kienreich K, Rutters F, de Jongh R, van Ballegooijen AJ, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep 2013;13:261–70.10.1007/s11892-012-0358-4Search in Google Scholar PubMed

3. Lee S, Clark SA, Gill RK, Christakos S. 1,25-Dihydroxyvitamin D3 and pancreatic β-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinol 1994;134:1602–10.10.1210/endo.134.4.8137721Search in Google Scholar PubMed

4. Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, et al. Relationship between insulin resistance and plasma vitamin D in adults. Diabetes Metab Syndr Obes 2014;7:297–303.10.2147/DMSO.S60569Search in Google Scholar PubMed PubMed Central

5. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, et al. Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010;33:1379–81.10.2337/dc09-2321Search in Google Scholar PubMed PubMed Central

6. Reis JP, von Mühlen D, Miller ER 3rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009;124:e371–9.10.1542/peds.2009-0213Search in Google Scholar PubMed PubMed Central

7. Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010;2010:351385.10.1155/2010/351385Search in Google Scholar PubMed PubMed Central

8. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call for action from the American Diabetes Association and the American Heart Association. Circulation 2006;113:2943–6.10.1161/CIRCULATIONAHA.106.176583Search in Google Scholar PubMed

9. Sakou I-I, Psaltopoulou T, Sergentanis TN, Karavanaki K, Karachaliou F, et al. Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach. J Pediatr Endocrinol Metab 2015;28:589–96.10.1515/jpem-2014-0431Search in Google Scholar PubMed

10. Levy-Marchal C, Arslain S, Cutfield W, Sinaiko A, Druet C, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocr Metab 2010;95:5189–98.10.1210/jc.2010-1047Search in Google Scholar PubMed PubMed Central

11. Group of China Obesity Task Force. The body mass index reference norm for screening overweight and obesity in Chinese children and adolescents. Chin J Epidemiol 2004;25:97–102. (in Chinese).Search in Google Scholar

12. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium of Food and Nutrition Board of Institute of Medicine of National Academies. DRI dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press, 2011:13–14.Search in Google Scholar

13. Challa AS, Makariou SE, Siomou EC. The relation of vitamin D status with metabolic syndrome in childhood and adolescence: an update. J Pediatr Endocrinol Metab 2015;28:1235–45.10.1515/jpem-2014-0485Search in Google Scholar

14. Rajakumar K, Heras JD, Lee SJ, Holick MF, Arslanian SA. 25-Hydroxyvitamin D concentrations and in vivo insulin sensitivity and β-cell function relative to insulin sensitivity in black and white youth. Diabetes Care 2012;35:627–33.10.2337/dc11-1825Search in Google Scholar

15. Lee DY, Kwon AR, Ahn JM, Kim YJ, Chae HW, et al. Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008–2010. Ann Pediatr Endocrinol Metab 2015;20:46–52.10.6065/apem.2015.20.1.46Search in Google Scholar

16. Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, et al. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. the Tromsø Study. PLoS One 2012;7:e37295.10.1371/journal.pone.0037295Search in Google Scholar

17. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, et al. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004; 89–90:121–125.10.1016/j.jsbmb.2004.03.115Search in Google Scholar

18. Maestro B, Davila N, Carranza MC, Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003;84:223–30.10.1016/S0960-0760(03)00032-3Search in Google Scholar

19. Maestro B, Molero S, Bajo S, D’avila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct 2002;20:227–32.10.1002/cbf.951Search in Google Scholar PubMed

20. Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, et al. The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol 2005;349:248–60.10.1016/j.jmb.2005.03.060Search in Google Scholar PubMed

Received: 2015-10-25
Accepted: 2016-2-9
Published Online: 2016-4-18
Published in Print: 2016-7-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Translation and psychometric properties of the Persian version of self-management of type 1 diabetes for adolescents
  4. Generic and disease-specific quality of life in adolescents with type 1 diabetes: comparison to age-matched healthy peers
  5. Relationship between HOMA-IR and serum vitamin D in Chinese children and adolescents
  6. Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children
  7. Pediatric thyroid nodules: ultrasonographic characteristics and inter-observer variability in prediction of malignancy
  8. Frequency of thyroid status monitoring in the first year of life and predictors for more frequent monitoring in infants with congenital hypothyroidism
  9. Biochemical, radiological, and genetic characterization of congenital hypothyroidism in Abu Dhabi, United Arab Emirates
  10. High prevalence of DUOX2 mutations in Japanese patients with permanent congenital hypothyroidism or transient hypothyroidism
  11. Children with severe Osteogenesis imperfecta and short stature present on average with normal IGF-I and IGFBP-3 levels
  12. Association between physical activity and bone in children with Prader-Willi syndrome
  13. CNDP1 genotype and renal survival in pediatric nephropathies
  14. 17-Hydroxyprogesterone responses to human chorionic gonadotropin are not associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome
  15. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China
  16. Case Reports
  17. Sertoli cell only syndrome with ambiguous genitalia
  18. Childhood parathyroid adenoma: a rare but important cause of nephrolithiasis
  19. A unique case of growth hormone and human chorionic gonadotropin treatment in a 45,X male with Y: autosome translocation and literature review
  20. Propionic acidemia: a Turkish case report of a successful pregnancy, labor and lactation
  21. Unusual phenotype of congenital adrenal hyperplasia (CAH) with a novel mutation of the CYP21A2 gene
  22. Central diabetes insipidus as a very late relapse limited to the pituitary stalk in Langerhans cell histiocytosis
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0422/pdf
Scroll to top button